Baxalta Ventures

Baxalta Ventures

Baxalta Ventures

Learn about Baxaltas values, company leadership, and our passion for improving patient care.
Follow us
21 Jun 2017

Syntimmune Closes $50 Million Series B Financing Led by Apple Tree Partners

businesswire
+2
25 May 2016
Undisclosed funding
29 Mar 2016
€7,000,000
Venture capital (Series A)
Baxalta Ventures, Utrecht Holdings, Medicxi Ventures